Monte Carlo calculation of radioimmunotherapy with ^90Y-, ^177Lu-, ^131I-, ^124I-, and ^188Re-nanoobjects: choice of the best radionuclide for solid tumour treatment by using TCP and NTCP concepts

DOI10.1155/2015/284360MaRDI QIDQ308774zbMATH OpenOpenAlexDBLPWikidataFDO

Authors S. Lucas, O. Feron, B. Gallez, B. Masereel, C. Michiels, T. Vander Borght

Publication date 6 September 2016

Published in Computational \& Mathematical Methods in Medicine (Search for Journal in Brave)

Copyright license Creative Commons Attribution 3.0 Unported

Full work available at URL https://doi.org/10.1155/2015/284360

zbMATH Keywords

monoclonal antibodiesnanoobjectsradioimmunotherapyradioisotopes

Mathematics Subject Classification ID

Monte Carlo methods (65C05) Medical applications (general) (92C50)

Recommendations

• Are more complicated tumour control probability models better?
• Immune system - tumour efficiency ratio as a new oncological index for radiotherapy treatment optimization
• Monte Carlo techniques in radiation therapy
• Multinomial model-based formulations of TCP and NTCP for radiotherapy treatment planning
• Linear quadratic and tumour control probability modelling in external beam radiotherapy

This page was built for publication: Monte Carlo calculation of radioimmunotherapy with \(^{90}\)Y-, \(^{177}\)Lu-, \(^{131}\)I-, \(^{124}\)I-, and \(^{188}\)Re-nanoobjects: choice of the best radionuclide for solid tumour treatment by using TCP and NTCP concepts

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q308774)